QRG Capital Management Inc. Buys 24,450 Shares of GE HealthCare Technologies Inc. $GEHC

QRG Capital Management Inc. lifted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 151.2% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 40,616 shares of the company’s stock after purchasing an additional 24,450 shares during the quarter. QRG Capital Management Inc.’s holdings in GE HealthCare Technologies were worth $2,891,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Laurel Wealth Advisors LLC bought a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at $26,000. Optima Capital LLC purchased a new position in GE HealthCare Technologies during the 4th quarter valued at about $27,000. Godfrey Financial Associates Inc. bought a new stake in GE HealthCare Technologies during the fourth quarter worth about $27,000. Montag A & Associates Inc. boosted its stake in GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after acquiring an additional 175 shares in the last quarter. Finally, Transamerica Financial Advisors LLC grew its holdings in GE HealthCare Technologies by 331.6% in the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 262 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, insider Frank R. Jimenez acquired 1,750 shares of the business’s stock in a transaction dated Thursday, April 30th. The stock was purchased at an average price of $60.45 per share, with a total value of $105,787.50. Following the transaction, the insider directly owned 93,932 shares in the company, valued at approximately $5,678,189.40. The trade was a 1.90% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO James Saccaro acquired 3,310 shares of GE HealthCare Technologies stock in a transaction dated Friday, May 1st. The stock was bought at an average price of $60.60 per share, with a total value of $200,586.00. Following the completion of the purchase, the chief financial officer directly owned 87,471 shares in the company, valued at $5,300,742.60. This represents a 3.93% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders have bought 21,847 shares of company stock worth $1,361,355. Insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC traded up $0.68 during midday trading on Tuesday, hitting $65.52. 489,377 shares of the stock traded hands, compared to its average volume of 4,349,116. The firm has a market capitalization of $29.80 billion, a P/E ratio of 15.70, a PEG ratio of 1.78 and a beta of 0.72. GE HealthCare Technologies Inc. has a one year low of $58.75 and a one year high of $89.77. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. The firm has a 50-day moving average of $63.60 and a two-hundred day moving average of $73.09.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The firm had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be given a $0.035 dividend. The ex-dividend date is Friday, July 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.35%.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on GEHC shares. Rothschild & Co Redburn decreased their target price on shares of GE HealthCare Technologies from $110.00 to $98.00 in a research note on Thursday, April 30th. JPMorgan Chase & Co. cut their price target on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a research note on Thursday, April 30th. Mizuho reduced their price target on GE HealthCare Technologies from $90.00 to $80.00 in a report on Thursday, April 30th. Barclays reduced their price objective on shares of GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating for the company in a research note on Thursday, April 30th. Finally, UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and decreased their target price for the stock from $75.00 to $69.00 in a report on Thursday, May 21st. Ten analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $80.20.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.